Ariana Harris

Now Available! Updated Goodwin's Guide To Biosimilars Litigation And Regulation In The U.S., 2023-2024

So You Want To Make A Biosimilar: Top Considerations Before BLA Submission

New Guidance & Ongoing Litigation: Summer 2023 Updates On The Inflation Reduction Act's Medicare Drug Pricing Negotiation Program

Think You Don't Need To Worry About Patents Before Commercializing Your Gene Or Cell Therapy Product? Think Again! The Safe Harbor And Lessons Learned From REGENXBIO V. Sarepta.

The Inflation Reduction Act & Medicare Pricing For Drugs And Biologics